Overview Sulforaphane to Reduce Symptoms of Schizophrenia Status: Completed Trial end date: 2019-11-11 Target enrollment: Participant gender: Summary The purpose of this study is to determine if taking a sulforaphane nutraceutical versus a placebo will reduce symptoms of schizophrenia when used in addition to standard antipsychotic medications. Phase: Phase 2 Details Lead Sponsor: Sheppard Pratt Health SystemTreatments: SulforafanSulforaphane